In what Spotlight understands to be a world-first, South Africa is on the brink of allowing pharmacists with the required permits to prescribe HIV medicines without people first having to get a script from a doctor or nurse. Catherine Tomlinson investigates how it will work and why it may be just the boost the country’s HIV response needs.
Around one in ten of the over seven million people living with HIV in South Africa are not aware that they have the virus in their bodies. One way to ensure more people are diagnosed more quickly is to make HIV self-tests more widely available. Tiyese Jeranji looks at what HIV Self Testing is, how it is done, and what government policy is on this type of HIV testing.
South Africa will delay introducing a new HIV and TB plan until 2024, Deputy President David Mabuza revealed on Wednesday. The plan is delayed to allow the country’s HIV and TB responses to recover from COVID-19-related disruptions. Laura Lopez Gonzalez reports for Spotlight.
We know antiretroviral therapy can prevent HIV infection, but can natural biological substances do the same? The results of a recent scientific trial have answered this question: Yes, using broadly neutralising antibodies. But what are broadly neutralising antibodies? How do they work? And when will the average person get access to them? Amy Green breaks down the science.
Antiretroviral (ARV) injections that may protect women from becoming HIV-positive, if proved to be safe and effective, will be a major step forward in the fight against the HIV pandemic. Siyabonga Kamnqa reports.